Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Promising PHP phase I/II results reported

March 20, 1997

International sepsis forum established with funding from Bayer

March 20, 1997

SA-7060: a dual NEP and ACE inhibitor from Santen

March 20, 1997

Sumitomo presents new Na+/H+-exchange inhibitor

March 20, 1997

Highly potent and selective ETA antagonist from Tanabe Seiyaku

March 20, 1997

Hirosaki University researchers present novel class Ib antiarrhythmic

March 20, 1997

Eisai discovers novel selective PDE I inhibitor

March 19, 1997

Novel Na+/H+-exchange inhibitor from Fujisawa with cardioprotective effects

March 19, 1997

Reduced risk of mortality found for losartan in ELITE study

March 19, 1997

Cardioprotective effects of KBR-9032

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...